VERIMMUNE
Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirects pre-existing pathogenic or childhood vaccine immune memory towards tumors.
VERIMMUNE
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2020-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.verimmune.com
Total Employee:
11+
Status:
Active
Contact:
+1 443 449 8836
Total Funding:
6.48 M USD
Technology used in webpage:
Pound Sterling Squarespace Hosted
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Georgiamune
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Investors List
Proxima Ventures Ltd
Proxima Ventures Ltd investment in Seed Round - VerImmune
Fosun Pharma
Fosun Pharma investment in Seed Round - VerImmune
Mana Ventures
Mana Ventures investment in Seed Round - VerImmune
Gaingels
Gaingels investment in Seed Round - VerImmune
Proxima Ventures Ltd
Proxima Ventures Ltd investment in Seed Round - VerImmune
Mana Ventures
Mana Ventures investment in Seed Round - VerImmune
NuFund Venture Group
NuFund Venture Group investment in Seed Round - VerImmune
Ulu Ventures
Ulu Ventures investment in Seed Round - VerImmune
SeedFolio
SeedFolio investment in Seed Round - VerImmune
Prox Ventures
Prox Ventures investment in Seed Round - VerImmune
Official Site Inspections
http://www.verimmune.com Semrush global rank: 11.28 M Semrush visits lastest month: 168
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "VerImmune"
VERIMMUNE
VerImmune is developing Anti-Tumor Immune Redirection (AIR): a breakthrough therapy that redirects immune memory against pathogens or childhood vaccines to target cancer.See details»
ABOUT US - VERIMMUNE
VerImmune is biotechnology company developing a novel first-in-class cancer therapy known as Anti-tumor Immune Redirection (AIR). This strategy utilizes a proprietary virus-inspired particle (ViP) technology platform that redirects pre …See details»
VerImmune - Crunchbase Company Profile & Funding
VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. VerImmune may be growing as it has successfully raised $3.1 million for its cancer therapy technology.See details»
VerImmune Company Profile 2024: Valuation, Funding & Investors …
Where is VerImmune headquartered? VerImmune is headquartered in Washington, DC. What is the size of VerImmune? VerImmune has 10 total employees. What industry is VerImmune in? …See details»
VerImmune Announces Over $3M Additional Funding
WASHINGTON, Sept. 20, 2023 /PRNewswire/ -- VerImmune Inc. ("VerImmune"), an early-stage biotechnology company specializing in the development of innovative products based on a novel Virus-inspired Particle (ViP™) …See details»
Verimmune Company Profile - Office Locations, Competitors
See insights on Verimmune including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
VerImmune - LinkedIn
VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer.See details»
Founding CEO & President at VerImmune - The Org
Joshua Weiyuan is currently serving as the Founding CEO & President of VerImmune, a biotechnology company focused on developing a first-in-class cancer therapy named Anti-tumor Immune Redirection (AIR).See details»
VerImmune - Funding, Financials, Valuation & Investors
VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.See details»
VERIMMUNE INC. Company Profile | Baltimore, MD | Competitors ...
Find company research, competitor information, contact details & financial data for VERIMMUNE INC. of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.See details»
VerImmune Completes $4.5 Million First Closing of Pre-Series A ...
VerImmune Inc., a venture-backed biotechnology company developing a groundbreaking Virus-inspired Particle (ViP™) platform technology, today announced the successful first closing of …See details»
Biotech startup VerImmune just raised $3.1M for its cancer …
Sep 25, 2023 · In a follow-on round, a local biotech company raised millions to help with the development of its cancer prevention tech. VerImmune, a startup based out of Johnson & …See details»
VerImmune Inc Announces Closing of Seed Financing to Further …
Washington DC | July 27, 2022 | VerImmune, Inc. (“VerImmune”), a biotechnology company developing new therapeutic modalities that aim to redirect the body’s pre-existing immunity …See details»
VerImmune Completes $4.5 Million First Closing of Pre-Series A ...
Sep 23, 2024 · VerImmune Inc (www.verimmune.com) is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases. …See details»
VerImmune Completes $4.5 Million First Closing of Pre-Series A ...
Sep 23, 2024 · VerImmune Inc., ("VerImmune"), a venture-backed biotechnology company developing a groundbreaking Virus-inspired Particle (ViP™) platform technology, today …See details»
Abstract LB117: Virus-inspired Particles (ViPs) harnessing ...
Apr 5, 2024 · VerImmune is pioneering a First-in-Class treatment known as “Anti-tumor Immune Redirection” (AIR). This approach repurposes a patient’s pre-existing anti-viral or childhood …See details»
News - VERIMMUNE
VerImmune and Fosun Pharma enter into an Exclusive License and Option Agreement for VerImmune’s Virus-inspired Particle (ViP) platform as Novel Immunotherapies in ChinaSee details»
1349 Redirecting immune memory for cancer treatment using …
These HCMV specific memory CD8+ T-cells are re-directed by VerImmune’s lead product, VERI-101, to attack tumors for destruction. VERI-101 consists of VerImmune’s proprietary platform …See details»
VerImmune - BIO Investor Forum | BIO
VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection (AIR). The strategy utilizes a proprietary tumor-specific, tumor …See details»
VerImmune Announces Research Collaboration with Janssen to …
Feb 9, 2022 · Under the terms of the collaboration, VerImmune will collaborate with Janssen immuno-oncology scientists to conduct feasibility studies to evaluate VerImmune’s proprietary …See details»